Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Page & Page: PMEA finalists 2018

Page & Page have been shortlisted for the "Excellence in Marketing Established Products" award for their work in the nutrition industry.

Page & Page Health

- PMLiVE

What’s in store in the final (maybe short-lived) pre-Brexit budget?

The UK pharma and biotech sectors are hoping for measures to support investment in R&D and manufacturing when Chancellor Philip Hammond delivers the last pre-Brexit budget later today.Hammond has however...

- PMLiVE

US pricing plan slammed for imposing “foreign price controls”

Trump returns to popular theme ahead of mid-term elections

- PMLiVE

In conversation with Pfizer’s Erik Nordkamp

Pfizer’s UK managing director and newly appointed ABPI President talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe

- PMLiVE

After mixed signals, will Eisai and Biogen press on with Alzheimer’s hopeful?

Sub-study aimed at addressing doubts raises more questions

Pharma: in search of the sustainable ‘win win’ with the NHS

Fiona Bride on how Novartis is responding to new models of care

- PMLiVE

BMS CEO tackles investor ‘frustrations’ on immuno-oncology

Company faces pressure from competitors in renal cell carcinoma

- PMLiVE

Novartis gains label boost for Cosentyx

Updated label allows dosing flexibility of up to 300mg

Celgene building

Celgene to launch five new products through to 2020

Two of which are CAR-T candidates

- PMLiVE

Roche’s new flu pill Xofluza approved in US

First novel treatment in decades, but hasn't shown superiority to Tamiflu

- PMLiVE

Alexion targets RNAi with $637m Dicerna deal

Bolsters pipeline ahead of Soliris patent protection loss

- PMLiVE

Keytruda hits survival targets in first-line kidney cancer

New data presented at ESMO congress

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links